Prognostic Impact of FLT3, NPM1 and CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia
Eurasian Journal of Medical Advances · 2026 · 39-45
DOI: 10.14744/ejma.260346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medical Advances, 2026. Verfasst von Serdar İleri und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The Eurasian Journal of Medical Advances (EJMA) is an open access, double-blind peer-reviewed medical journal publishing qualified research across all medical investigations. The journal is published quarterly in March, June, September and December.
Zitieren
APA
İleri, S., & Ayyıldız, O. (2026). Prognostic Impact of FLT3, NPM1 and CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia. Eurasian Journal of Medical Advances, 39-45. https://doi.org/10.14744/ejma.260346
Vancouver
İleri S, Ayyıldız O. Prognostic Impact of FLT3, NPM1 and CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia. Eurasian Journal of Medical Advances. 2026:39-45. doi:10.14744/ejma.260346
BibTeX
@article{leri2026,
author = {İleri, Serdar and Ayyıldız, Orhan},
title = {Prognostic Impact of FLT3, NPM1 and CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia},
journal = {Eurasian Journal of Medical Advances},
year = {2026},
pages = {39--45},
doi = {10.14744/ejma.260346}
}
EUVIMED